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The gastrointestinal tract is one of the
most colonized organs and harbors a
large microbial population (1014 bacteria)
that has co-evolved with us establishing a
finely tuned symbiosis (Ley et al., 2008).
As a result of their occurrence in com-
plex mixtures, their combined genomes
or metagenome, contain 150-fold more
genes respect to humans, therefore pro-
viding us with novel functions (Qin et al.,
2010). Increasing evidences show that the
disruption of this symbiosis may lead
to pathologies such as obesity or to an
increased risk of developing inflamma-
tory bowel disease (Ott et al., 2004).
Since the intestine is constantly exposed
to an almost limitless number of for-
eign antigens (i.e., food-derived materials,
commensal microbes, pathogenic bacteria,
viruses and parasites), it is of fundamental
importance that an appropriate immune
homeostasis in the gut mucosa is estab-
lished and maintained. This requires a
highly sophisticated immunological regu-
latory systems achieved by the coopera-
tive interaction of intestinal epithelial cells
(IECs) and mucosal cells of the immune
response (Goto and Kiyono, 2011). The
IECs comprise columnar epithelial cells,
Paneth cells, endocrine cells and goblet
cells (van der Flier and Clevers, 2009)
and consist in the first physical barrier
between the host and the external environ-
ment. Owing to many signals transmission
from epithelial cells to the various innate
and acquired types of mucosal cells of the
immune response, these cells regulate each
other resulting in intestinal immunologi-
cal homeostasis.
To gain information about the com-
position of gut microbiota communi-
ties, their molecular interactions with the
host and their impact on various host
functional processes, several studies have
been carried out on germ-free animals
by coupling genomics and bioinformat-
ics techniques (Hooper and Gordon, 2001;
O’Hara and Shanahan, 2006). However,
little is known about the molecular mech-
anisms of such modulations and the host
post-transcriptional gene expression regu-
lation by microRNAs.
MicroRNAs (miRNAs) are short
(∼22 nt) non-coding RNAs that con-
trol gene expression by base pairing
with 3′-untraslated regions (3′UTRs) of
their regulated transcripts. MiRNA bio-
genesis occurs through various steps in
which are involved Drosha and Dicer,
two main RNase III endonucleases.
Precursor miRNAs (pre-miRNAs) are
∼70 nucleotide-long RNA molecules with
a characteristic hairpin structure. They
originate in longer primary transcripts
(pri-miRNAs) that are cleaved in ani-
mals by the Drosha endonuclease in the
nucleus (Lee et al., 2003). Following the
export of pre-miRNAs to the cytoplasm by
Exportin-5, the loop region of the hairpin
is removed by the Dicer endonuclease to
produce a short, double-stranded RNA
(dsRNA) (Cullen, 2004). Based on the
thermodynamic stability of each end of
this duplex (O’Toole et al., 2006), one of
the strands is preferentially incorporated
in the RNA-induced silencing complex
(RISC), producing a biologically active
mature miRNA (generally the -5p miR)
(Bartel, 2004), while the inactive strand
(the -3p miR) is degraded (Kim, 2005).
The coupling of the active miRNA to
the 3′UTR of its target gene, facilitates
mRNA degradation or translation inhibi-
tion (Djuranovic et al., 2012). As a direct
consequence, miRNAs regulate many bio-
logical processes and have critical roles
in cell proliferation, differentiation and
death (Shivdasani, 2006; Gomase and
Parundekar, 2009).
However, the role of miRNAs in micro-
biota host interactions is beginning to be
investigated (Figure 1A) (Dalmasso et al.,
2011; Kaser et al., 2011). Dalmasso et al.
used germ-free mice colonized with the
microbiota from pathogen-free mice to
study whether miRNAs are involved in
microbiota-mediated regulation of host
gene expression (Dalmasso et al., 2011).
Their miRNA expression analysis revealed
that nine miRNAs were differentially
expressed in the ileum and colon of col-
onized mice compared to germ-free mice.
By overlapping the predicted targets of
deregulated miRNAs with DNA microar-
ray gene expression profiling, they found
that the up-regulation of miR-665 induced
a significant down-regulation of the ATP-
binding cassette sub-family C member
3 (Abcc3) gene (a target of miR-665).
Abcc3 belongs to the multidrug resistance-
associated protein family, which medi-
ates the metabolism of xenobiotics and
endogenous toxins (Hooper et al., 2001).
A similar study by Singh et al. emphasized
the emerging interplay between endoge-
nous microbiota and caecal miRNA signa-
ture (Singh et al., 2012). In fact, intestinal
miRNAs have been proven experimentally
to have roles in the regulation of neonatal
nutrient metabolism (Liao and Lonnerdal,
2010), in the control of intestinal fluid
and electrolyte transport (Sansom et al.,
2010) and permeability (Zhou et al., 2010),
affecting also intestinal epithelial cell dif-
ferentiation (Dalmasso et al., 2010) and
maturation (Zeng et al., 2009). By using
germ-free and conventionally raised mice,
the impact of the endogenous microbiota
on the global expression of caecal miRNAs
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FIGURE 1 | (A) Research projects for the study of the interplays between gut
microbiota and miRNAs. (B) Intestinal epithelial differentiation and TH2
immune responses are regulated by miRNAs: in wild type mice, Dicer1 and
miR-375 inhibit KLF5, a known antagonist of KLF4 that promotes the
differentiation of goblet cells via KLF4. Helminth infection induces TH2
cytokines, especially IL-13, which leads to epithelial expression of miR-375
and goblet-cell maturation via PI3K. Moreover, miR-375 also induces TSLP to
accelerate TH2 immune responses to parasite infections. In Dicer1gut mice,
depletion of Dicer1 or miR-375 results in fewer goblet cells and diminished
TH2 responses. The gut microbiota can be involved in the induction and
regulation of miRNA expression either for active or quiescent immunity.
Likewise, other miRNAs can be involved in the generation of optimal
protective immunity to various pathogens. This figure has been adapted from
(Goto and Kiyono, 2011).
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in vivo has been investigated, showing that
the murine miRNA signature in the cae-
cum is affected by the presence of the
microbiota (Singh et al., 2012). Moreover,
authors found that 34 putative miRNA
target genes encode for proteins involved
in the regulation of the intestinal bar-
rier function (i.e., glycosylation enzymes,
junctional proteins, proteins found in the
mucus layers) and in the immune reg-
ulation (i.e., MHC I and II proteins).
They found that the expression of miR-
NAs depends on the endogenous micro-
biota and that 16 unique miRNAs were
deregulated between germ-free and con-
ventional raised mice. By cross-matching
the list of intestinal barrier genes pre-
dicted to be modulated by differentially
expressed miRNAs, with genes already
demonstrated to be deregulated in the
jejunal mucosa of intestinal-specific Dicer
knock-out mice (McKenna et al., 2010),
the authors supported the hypothesis that
gut commensals impact the intestinal bar-
rier via miRNAs expression modulation.
Therefore, the miRNAs modulation by
gut microbiota may potentially affect the
expression of a huge number of host genes,
so far unexpected, especially in those dis-
eases where the microbiota composition is
altered toward less desirable species. In this
context, the use of synthetic miRNAs could
represent a potentially novel therapeutic
perspective.
Another example of the role of miR-
NAs in affecting the intestinal epithelial
monolayer, has been provided by Biton
et al. by using mice with an inducible
intestinal epithelial cell–specific deficiency
in Dicer1 (Dicer1gut) (Biton et al., 2011).
They found that Dicer1 deletion in the
mice gut lead to goblet-cell depletion and
that the regulation of goblet-cell differ-
entiation is dependent on the expression
of miR-375. In fact, the expression of
this miRNA is able to inhibit the transla-
tion of KLF5, an antagonist of the goblet
cell–differentiation factor KLF4, support-
ing the differentiation of goblet cells.
Moreover, they observed a lower expres-
sion of IL-4, IL-5, and IL-13 in Dicer1gut
mice and an enhanced susceptibility to
helminth parasite Trichuris muris infec-
tion (Figure 1B). IL-13, presumably sup-
plied by TH2 cells, induces miR-375 in
IECs in vitro and a down-stream pro-
duction of the TH2-facilitating epithelial
cytokine TSLP, indicating an appropriately
balanced TH2 feed-forward loop regulated
by miR-375. On the basis of their results,
the authors suggested that miR-375 directs
the differentiation of goblet cells and the
promotion of antiparasitic TH2 immune
responses. As miR-375 expression is very
high in the human intestine (Wu et al.,
2010), mucosal expression of this partic-
ular miRNA might also be important in
the regulation of intestinal homeostasis
and protection against parasite infection in
humans (Goto and Kiyono, 2011). Further
investigation should allow answering to
many open questions still remaining,
such as whether there are other miRNAs
involved in this process or whether there
are other miR-375 targets relevant to the
differentiation of goblet cells or in the
maintenance of gut immunological home-
ostasis. It is quite easily conceivable that in
a near future we will assist to the devel-
opment of innovative mucosal miRNA–
targeted treatments and to the diagnosis
of pathogenic mucosal conditions such as
allergy, inflammatory bowel diseases and
colon cancer, as well as infection by bac-
teria, viruses and parasites by employing
specific miRNA-designed tests.
One of the most recently emerging
and appealing concept is the role of
toll-like receptors (TLRs) as potential
mediators between gut microbiota and
miRNAs/mRNAs modulation in humans.
In fact, it has been recognized clearly that
host gene expression is regulated by gut
microbiota along the length of the gut
and that microorganisms recognition is
mediated by TLRs through the adaptor
molecule MyD88 (Dalmasso et al., 2011;
Larsson et al., 2012). Therefore TLRs,
localized at the interface between the
microbiota and the molecular machinery
of host cells, may be key players in these
relationships. In a recent study, Chassin
et al. found that the TLR-4-mediated tran-
scriptional activation of IECs observed in
mice immediately after birth, was induced
by oral ingestion of environmental endo-
toxin and induced a post-transcriptional
down-regulation of epithelial IRAK1
protein expression, protecting further
from bacteria-induced epithelial dam-
ages (Chassin et al., 2010). According to
evidences showing that IRAK-1 expres-
sion is regulated by miR-146a (Taganov
et al., 2006), miR-146a levels declined
only in concomitance to the increase of
IRAK-1 protein level, whereas miR-146a
silencing induced IRAK1 protein expres-
sion.Moreover, authors demonstrated that
the oral treatment with anti-miRNAs is a
viable option to down-regulate the expres-
sion of miR-146a in intestinal epithelial
cells.
Another study focusing on the micro-
biota regulation of miRNAs expression
and on the maintenance of intestinal
homeostasis, has been reported by Xue
et al. who reported a connection between
the expression of miR-10a and of its tar-
get IL-12/IL-23p40, a key molecule for
innate immune responses to commen-
sal bacteria (Xue et al., 2011). They also
found that commensal bacteria down-
regulated dendritic cell miR-10a expres-
sion via TLR–TLR ligand interactions
through aMyD88-dependent pathway and
that mice with colitis expressed higher lev-
els of IL-12/IL-23p40 and lower level of
gut miR-10a, compared to control mice,
opening new perspectives for the study of
miRNAs regulation in intestinal diseases.
In the field of RNA silencing, very
close to that of miRNAs for their common
mechanism of action, a novel approach
exploiting engineered bacteria has been
reported few years ago (Xiang et al.,
2006). This approach holds great promise
for functional genomics in mammalian
systems and for other in vivo appli-
cations, since it demonstrates that the
trans-kingdom RNA interference (RNAi)
process is feasible both in vitro and in vivo.
Authors employed E. coli engineered to
produce short hairpin RNAs, by the use of
a plasmid that they termed TRIP (trans-
kingdom RNAi plasmid). This vector con-
tains Inv and HlyA encoding for invasin,
and listeriolysin O, respectively, enabling
the entry into β1-integrin-positive mam-
malian cells and the release of genetic
materials from internalized vesicles. By
co-culturing human colon cancer cells
(SW480) in vitro with the engineered
E. coli, a significant down-regulation of
a specific target gene has been observed,
demonstrating the effectiveness of the
trans-kingdom RNAi mechanism in vitro.
By oral or intravenous administration
of the engineered E. coli, the authors
demonstrated also an efficient gene silenc-
ing in the intestinal epithelium and in
human colon cancer xenografts in mice,
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suggesting a clinically feasible approach
to the in vivo application of RNAi tech-
nology. Most interestingly, this trans-
kingdom RNAi approach not only can be
exploited clinically to silence genes in the
colonic mucosa and in other organs col-
onized by bacteria (i.e., oral cavity, uri-
nary bladder, and female genital tract), but
also suggest the speculative but intrigu-
ing possibility that such RNAi mechanism
may occur also in natural interactions such
as infections, commensal interaction and
symbiosis.
In conclusion, I described two works
(Dalmasso et al., 2011; Singh et al., 2012)
dealing with a differential expression of
miRNAs in different areas of the intestinal
tract as a function of microbiota compo-
sition. In these cases, intestinal microbiota
are the “actors.” Conversely, we should also
think to miRNAs as “actors” when, under
proper conditions, influence the regula-
tion of goblet-cell differentiation (Biton
et al., 2011). Therefore, an interconnected
cycle could be envisaged where miRNAs
and gut microbiota are the two main part-
ners. Two interesting approaches (use of
engineered vectors and the oral delivery of
anti-miRNAs) (Chassin et al., 2010; Xue
et al., 2011) have emerged as interesting
possibilities to study experimentally the
interplays between miRNA and gut micro-
biota, and their mutual role in influencing
host immune system and related processes.
Therefore, although still a few, the studies
reported so far emphasize that we cannot
ignore that “our other genome” is inti-
mately linked to “our natural miRNome.”
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